| SERES THERAPEUTICS |
| USA |
| Gesundheit |
| US81750R2013 / A413XF |
| 1S90 (Frankfurt) / MCRB (NASDAQ) |
| FRA:1S90, ETR:1S90, 1S90:GR, NASDAQ:MCRB |
| - |
| https://www.serestherapeu.. |
|
Seres Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development of live biotherapeutic products that utilize carefully selected consortia of live bacteria to modulate the human microbiome. The company focuses on inn..
>Volltext.. |
| 72.94 Mio. EUR |
| 104.33 Mio. EUR |
| 0.68 Mio. EUR |
| -77.68 Mio. EUR |
| 4.92 Mio. EUR |
| 0.71 EUR |
| 71.73 Mio. EUR |
| 39.57 Mio. EUR |
| 0.97 Mio. EUR |
| 2.37 |
| - |
| - |
| - |
| - |
| - |
| - |
| SERES THERAPEUTICS, SERES THERAPEUTIC |
| 01.04.26 |
|